Ketamine enhances structural plasticity in human dopaminergic neurons:possible relevance for treatment-resistant depression

被引：3
|
作者：
Ginetta Collo [1 ,2 ]
Emilio Merlo Pich [3 ,4 ]
机构：
[1] Department of Molecular and Translational Medicine,Section of Pharmacology,University of Brescia
[2] Department of Biomedicine,University of Basel
[3] Neuroscience Therapeutic Area Unit,Takeda Pharmaceuticals International
来源：
Neural Regeneration Research | 2018年 / 13卷 / 04期
关键词：
MEK; ERK; Ketamine enhances structural plasticity in human dopaminergic neurons:possible relevance for treatment-resistant depression; TRD; MDD;
D O I：
暂无
中图分类号：
R749.4 [情感性精神病];
学科分类号：
100205 ;
摘要：
Depression refers to a series of mental health issues characterized by loss of interest and enjoyment in everyday life,low mood and selected emotional,cognitive,physical and behavioral symptoms.Depression is a common disorder,affecting 5–15%of the general population.When diagnosed as major depressive disorder(MDD),patients are currently
引用
收藏
页码：645 / 646
页数：2
相关论文
共 50 条
  • [1] Ketamine enhances structural plasticity in human dopaminergic neurons: possible relevance for treatment-resistant depression
    Collo, Ginetta
    Pich, Emilio Merlo
    NEURAL REGENERATION RESEARCH, 2018, 13 (04) : 645 - 646
  • [2] Ketamine and Pramipexole Promote Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF/TrkB and mTOR Mediated Signalling: Possible Relevance for Treatment-Resistant Depression
    Pich, Emilio Merlo
    Collo, Ginetta
    Cavalleri, Laura
    Fedele, Stefania
    Chiamulera, Cristiano
    Millan, Mark J.
    Spano, PierFranco
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S526 - S527
  • [3] Intranasal Ketamine in Treatment-resistant Depression
    Lapidus, Kyle A.
    Levitch, Cara F.
    Soleimani, Laili
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S361 - S361
  • [4] Oral ketamine for treatment-resistant depression
    Kang, Seema
    LANCET PSYCHIATRY, 2018, 5 (11): : 877 - 877
  • [5] Esketamine/ketamine for treatment-resistant depression
    Lacerda, Acioly L. T.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (06) : 579 - 580
  • [6] KETAMINE FOR ADOLESCENT TREATMENT-RESISTANT DEPRESSION
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S345 - S345
  • [7] SUBLINGUAL KETAMINE FOR TREATMENT-RESISTANT DEPRESSION
    Hyde, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 154 - 154
  • [8] A systematic review of ketamine for treatment-resistant depression
    Patel, Reshmee
    Loh, Feng-Hua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 132 - 132
  • [9] The use of subcutaneous ketamine for treatment-resistant depression
    Vargas Alves Nunes, A.
    Carrara, E.
    Odebrecht Vargas Nunes, S.
    Fernandes Jorge, I.
    Alves, E.
    Haddad, M.
    EUROPEAN PSYCHIATRY, 2019, 56 : S95 - S95
  • [10] Comparative Efficacy of Ketamine in Treatment-Resistant Depression
    Kurt, Hatice Guncu
    Altinay, Murat
    Anand, Amit
    PSYCHIATRIC ANNALS, 2020, 50 (02) : 62 - 67
12345